Home Daily Stock Opinions and Ratings Stressgen Biotechnologies Corp (SSB-T)

Trending stocks today

MDA Ltd. Microsoft Corp Morguard Corporation CNHI Industrial Halliburton Co Cenovus Energy Chartwell Retirement Residences Granite REIT Bank of America Chevron Texaco Dycom Industries Tesla Inc Verizon Communications British American Tobacco RenaissanceRe Holdings United Therapeutics Corp. Keg Royalties Income Fund CGI Group (A) Yum China Holdings Inc Brookfield Infrastructure Partners

Stressgen Biotechnologies Corp (SSB-T)

NEW AI Investor Insights
0 watching

0.00
0.00 (0.00%) 1d
0
DON'T BUY

Stressgen Biotechnologies Corp(SSB-T)

26/07/2005
Stressgen Biotechnologies Corp
A lottery ticket! The company has gone into orphan status. Have disappointed investors many, many times. They keep needing money. Very risky.
biotechnology / pharmaceutical
Peter Hodson
$0.370
No
UnlockRating
DON'T BUY

Stressgen Biotechnologies Corp(SSB-T)

12/11/2004
Stressgen Biotechnologies Corp
Trying to raise $50 million which is equivalent/more than their entire market cap.
biotechnology / pharmaceutical
Duncan Stewart
$0.440
No
UnlockRating
PAST TOP PICK

Stressgen Biotechnologies Corp(SSB-T)

09/11/2004
Stressgen Biotechnologies Corp
(A Top Pick June 14/04. Down 56%.) They continue to lose money. They'll have to get something through their pipeline quickly that deals with cancer. Doesn't look good.
biotechnology / pharmaceutical
Benj Gallander
$0.455
No
UnlockRating
TOP PICK

Stressgen Biotechnologies Corp(SSB-T)

15/06/2004
Stressgen Biotechnologies Corp
Holds this stock personally. Risky could double.
biotechnology / pharmaceutical
Benj Gallander
$1.060
Owned
UnlockRating
TRADE

Stressgen Biotechnologies Corp(SSB-T)

05/12/2003
Stressgen Biotechnologies Corp
A field that you have to be really wary of. Many of them have a very high burn rate. Although their trials were fast tracked, this does not necessarily mean continued success.
biotechnology / pharmaceutical
Benj Gallander
$1.930
No
UnlockRating
DON'T BUY

Stressgen Biotechnologies Corp(SSB-T)

04/12/2003
Stressgen Biotechnologies Corp
Have restructured and will need more money.
biotechnology / pharmaceutical
Peter Hodson
$2.130
No
UnlockRating
BUY

Stressgen Biotechnologies Corp(SSB-T)

07/10/2003
Stressgen Biotechnologies Corp
Very volatile. Developing a product for HBV (a sexually transmitted disease), which has a large market. In phase two. Has a partnership with Roach and has enough cash to probably last into 2005.
biotechnology / pharmaceutical
John Sinkins, CFA
$2.040
No
UnlockRating
DON'T BUY

Stressgen Biotechnologies Corp(SSB-T)

30/06/2003
Stressgen Biotechnologies Corp
On their watch list. Lost a lot of maney last year.
biotechnology / pharmaceutical
Benj Gallander
$1.710
No
UnlockRating
BUY ON WEAKNESS

Stressgen Biotechnologies Corp(SSB-T)

14/05/2003
Stressgen Biotechnologies Corp
A speculative stock. Has to move through the regulatory gateway. Meets a lot of technical resistance at the $1.81 level. Try to pick up near its support level of $1.25.
biotechnology / pharmaceutical
Lou Schizas
$1.780
Unknown
UnlockRating
BUY

Stressgen Biotechnologies Corp(SSB-T)

12/05/2003
Stressgen Biotechnologies Corp
They are far enough into their trials that investors are now paying more attention. Relatively cheap. Management is OK.
biotechnology / pharmaceutical
Peter Hodson
$1.900
Unknown
UnlockRating
BUY

Stressgen Biotechnologies Corp(SSB-T)

02/10/2002
Stressgen Biotechnologies Corp
Outlook is quite good and the price is at a good level.
biotechnology / pharmaceutical
Mike Weir
$2.450
Unknown
UnlockRating
BUY

Stressgen Biotechnologies Corp(SSB-T)

26/08/2002
Stressgen Biotechnologies Corp
At a good level. Has mad a good agreement with a large pharmaceutical.
biotechnology / pharmaceutical
Mike Weir
$3.250
Unknown
UnlockRating
WEAK BUY

Stressgen Biotechnologies Corp(SSB-T)

17/05/2002
Stressgen Biotechnologies Corp
In the final stage of their clinical trials. Will be a couple of years before you know if the product works.
biotechnology / pharmaceutical
Bruce Cooper
$4.500
Unknown
UnlockRating
WEAK BUY

Stressgen Biotechnologies Corp(SSB-T)

02/05/2002
Stressgen Biotechnologies Corp
Well along on the approval line. Product seems to be good. The sector is suffering. A higher risk.
biotechnology / pharmaceutical
Bruce Cooper
$3.530
Unknown
UnlockRating
WAIT

Stressgen Biotechnologies Corp(SSB-T)

15/01/2002
Stressgen Biotechnologies Corp
Fairly risky, but a good risk/reward ratio. In phase 3 trials. Could double if they get into a good partnership.
biotechnology / pharmaceutical
Bruce Cooper
$5.500
Unknown
UnlockRating
Showing 1 to 15 of 23 entries
Next PageNext Page

Stressgen Biotechnologies Corp(SSB-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Stressgen Biotechnologies Corp is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Stressgen Biotechnologies Corp(SSB-T) Frequently Asked Questions

What is Stressgen Biotechnologies Corp stock symbol?

Stressgen Biotechnologies Corp is a OTC stock, trading under the symbol SSB-T on the (). It is usually referred to as or SSB-T

Is Stressgen Biotechnologies Corp a buy or a sell?

In the last year, there was no coverage of Stressgen Biotechnologies Corp published on Stockchase.

Is Stressgen Biotechnologies Corp a good investment or a top pick?

Stressgen Biotechnologies Corp was recommended as a Top Pick by on . Read the latest stock experts ratings for Stressgen Biotechnologies Corp.

Why is Stressgen Biotechnologies Corp stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Stressgen Biotechnologies Corp worth watching?

In the last year 0 stock analysts on Stockchase covered Stressgen Biotechnologies Corp. The stock is worth watching.

What is Stressgen Biotechnologies Corp stock price?

On , Stressgen Biotechnologies Corp (SSB-T) stock closed at a price of $.

Your Watchlist

Add stocks to watchlist to monitor them daily and get important alerts.

Get Access To Watchlist

Latest Buy Signals

FTS-TFortis Inc.
Fortis Inc.
$52.69
0.31 (0.58%)
BIP.UN-TBrookfield Infrastructure Partners
Brookfield Infrastructure Partners
$37.08
0.82 (2.16%)
BNS-TBank of Nova Scotia
Bank of Nova Scotia
$64.48
0.34 (0.52%)
TD-TToronto Dominion
Toronto Dominion
$79.46
0.61 (0.76%)
YUMC-NYum China Holdings Inc
Yum China Holdings Inc
$37.22
0.34 (0.91%)
Advertising

Today's Top Picks

BIP.UN-TBrookfield Infrastructure Partners
Brookfield Infrastructure Partners
$37.08
0.82 (2.16%)
YUMC-NYum China Holdings Inc
Yum China Holdings Inc
$37.22
0.34 (0.91%)
GIB.A-TCGI Group (A)
CGI Group (A)
$142.83
-0.28 (-0.20%)
KEG.UN-TKeg Royalties Income Fund
Keg Royalties Income Fund
$14.46
-0.03 (-0.18%)
UTHR-QUnited Therapeutics Corp.
United Therapeutics Corp.
$237.16
1.85 (0.77%)

Popular Articles

Questrade Review: Pros & Cons of Trading with Questrade Canada (2021) Steady Eddys: 3 Stable Stocks Between Safety and Risk: 3 Safe and Gambling Stocks 3 Oversold Stocks to Take Advantage of 5 ETFs for Index Investing

Latest Sell Signals

AP.UN-TAllied Properties REIT
Allied Properties REIT
$17.00
0.46 (2.63%)
TSLA-QTesla Inc
Tesla Inc
$148.95
-0.98 (-0.66%)
CTC.A-TCanadian Tire Corporation Ltd. (A)
Canadian Tire Corporation Ltd. (A)
$130.50
0.94 (0.72%)
CWL-TCaldwell Partners Int'l (A)
Caldwell Partners Int'l (A)
$0.80
0.02 (2.44%)
TSLA-QTesla Inc
Tesla Inc
$148.95
-0.98 (-0.66%)

Most Recent Experts

Blumas

Chris Blumas

at Raymond James Investment Counsel Ltd.

Panic-Proof (Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Buzzing

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Reid

Gordon Reid

GoodReid Investment Counsel

Stockchase

Stockchase Insights

5i Research

Advertising
Advertising
logoTop pickslogoStockslogoRecentlogoWatchlist
© Stockchase Inc.